Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/19/1991 | US5001116 Inhibition of angiogenesis |
03/19/1991 | US5000962 Long acting diltiazem formulation |
03/19/1991 | US5000961 Tert-butyl derivatives of benzylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them |
03/19/1991 | US5000956 Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
03/19/1991 | US5000950 Agent for the treatment of wounds |
03/19/1991 | US5000888 Process for spray drying riboflavin to produce a granulate product having low binder content |
03/19/1991 | CA2065347A1 Oral anticoagulant/platelet inhibitor low dose formulation |
03/19/1991 | CA2025524A1 Pharmacologically active compound, preparation and use |
03/19/1991 | CA2025118A1 Preservative for ophthalmic solutions |
03/19/1991 | CA2023763A1 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method |
03/19/1991 | CA2013961A1 Substituted isoquinolines & method of using same |
03/19/1991 | CA1281722C Process for producing 3-imidazolylmethyltetrahydrocarbazolones |
03/19/1991 | CA1281721C Process for producing 3-imidazolyl-methyltetrahydrocarbazolones |
03/19/1991 | CA1281718C Derivatives of 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5- acetic acid |
03/19/1991 | CA1281713C Process for preparing new penem compounds |
03/19/1991 | CA1281712C Cephalosporin derivatives and antibiotics containing the same |
03/19/1991 | CA1281656C Process for treating metastasis of cancerous tumors |
03/19/1991 | CA1281655C Treatment of oral diseases |
03/19/1991 | CA1281654C Dihydropyridine spray, process for its preparation and its pharmaceutical use |
03/19/1991 | CA1281653C Opthlamic use of quinolone and napththyridine antibiotics |
03/19/1991 | CA1281652C Readily absorbable pharmaceutical composition |
03/19/1991 | CA1281651C Water soluble polyvinyl lactam-drug complexes |
03/19/1991 | CA1281650C Aqueous preparation containing cyclodextrin |
03/19/1991 | CA1281648C Remedy for bone disease containing organogermanium compound |
03/17/1991 | WO1991004252A1 New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and manufacture and use of said compounds |
03/17/1991 | CA2025358A1 Treatment |
03/16/1991 | WO1991004250A1 2-substituted-1(4)-aryl piperazines and the process for their preparation |
03/16/1991 | WO1991004046A1 Gamma glutamyl transferases for treating diseases |
03/16/1991 | WO1991004022A1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
03/16/1991 | CA2067156A1 2-substituted-1(4)-aryl piperazines and the process for their preparation |
03/16/1991 | CA2065157A1 Gamma glutamyl transferases for treating diseases |
03/16/1991 | CA2025356A1 Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
03/16/1991 | CA2025310A1 Methods of treating neurodegenerative conditions |
03/16/1991 | CA2024283A1 3,4,5,6-tetrahydro-2h 1,7,4-benzodioxazonines as cardiovascular agents |
03/16/1991 | CA2023936A1 Diol sulfonamide and sulfinyl renin inhibitors |
03/15/1991 | WO1991004025A1 Novel macrocyclic compounds and novel method of treatment |
03/15/1991 | CA2065425A1 Macrocyclic compounds and novel method of treatment |
03/14/1991 | WO1991004255A1 Antiviral tetrahydroimidazo[1,4]benzodiazepines |
03/14/1991 | DE3930206A1 Hypolipaemic pharmaceutical prods. - comprising combination of cholestyramine and drug of vibrate type |
03/14/1991 | DE3930168A1 Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste |
03/14/1991 | CA2064782A1 Antiviral tetrahydroimidazol [1,4] benzodiazepines |
03/14/1991 | CA2025202A1 Phenylalkanoyl substituted imidazo {4,5-c} pyridines |
03/14/1991 | CA2025162A1 Non-effervescent ibuprofen compositions |
03/14/1991 | CA2025150A1 Pyridinyl-quinolone compounds, their preparation and use |
03/14/1991 | CA2025084A1 Heteroaryl substituted imidazo [4,5-c] pyridines |
03/13/1991 | EP0417060A2 Bicyclic tetrahydroxypyrrolizidine |
03/13/1991 | EP0417059A2 Bicyclic tetrahydroxylated pyrrolizidines |
03/13/1991 | EP0417027A1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |
03/13/1991 | EP0417003A2 Use of antiprogestomimetics for stimulating ovulation |
03/13/1991 | EP0416953A2 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0.3,8]undec-2-ene-2-carboxylic acid derivatives |
03/13/1991 | EP0416952A2 4-(1'-Oxocyclohex-2'-yl)azetidin-2-one derivatives |
03/13/1991 | EP0416951A1 Medicaments comprising salmeterol and fluticason |
03/13/1991 | EP0416950A1 Medicaments |
03/13/1991 | EP0416925A2 Use of 4-hydroxy-alpha 1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation |
03/13/1991 | EP0416855A2 Fatty acids for the treatment and prevention of skin damage caused by radiotherapy |
03/13/1991 | EP0416842A1 Solid matrix system for transdermal drug delivery |
03/13/1991 | EP0416841A2 Novel use of 6-[[3-[4-(2- methoxyphenyl)-1-piperazinyl] propyl]amino]-1,3-dimethyluracil for preparing a pharmaceutical for treating urinary obstruction |
03/13/1991 | EP0416816A1 Hyposensitization agent |
03/13/1991 | EP0416814A2 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates |
03/13/1991 | EP0416810A2 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates |
03/13/1991 | EP0416804A1 External preparation containing amusulosin |
03/13/1991 | EP0416773A2 Vitamin B12 composition |
03/13/1991 | EP0416754A2 A novel substituted pyrazine, formulations thereof and use in medicine |
03/13/1991 | EP0416749A2 Substituted 4-aminoquinolines |
03/13/1991 | EP0416743A1 Antivirale Verwendung von Zusammensetzungen bestehend aus EFAs und Interferon |
03/13/1991 | EP0416739A1 Pharmaceutical compositions containing penciclovir |
03/13/1991 | EP0416736A2 Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one |
03/13/1991 | EP0416722A2 Pharmaceutical compositions having differential drug release rate |
03/13/1991 | EP0416689A2 Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
03/13/1991 | EP0416678A1 Topical compositions containing Defibrotide |
03/13/1991 | EP0416677A1 Compositions for topical cosmetic use containing depolymerized nucleic acids |
03/13/1991 | EP0416609A2 Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds |
03/13/1991 | EP0416605A1 Novel oxetanocin derivatives and their salts as well as use thereof |
03/13/1991 | EP0416604A2 PAF-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation |
03/13/1991 | EP0416581A1 Substituted N-benzylpiperidine amides |
03/13/1991 | EP0416575A2 Drug delivery compositions based on biological materials and methods for preparing such compositions |
03/13/1991 | EP0416527A2 Prostaglandin-containing liposome preparations |
03/13/1991 | EP0416521A1 N-Benzyltropaneamides |
03/13/1991 | EP0416520A1 Tricyclic quinolizine amides |
03/13/1991 | EP0416502A1 A pharmaceutical composition having antitumor activity and preparation for its manufacture |
03/13/1991 | EP0416499A2 Benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them |
03/13/1991 | EP0416479A1 1,5-Benzothiazepine derivatives and preparation thereof |
03/13/1991 | EP0416410A1 Piperaziniocephalosporins |
03/13/1991 | EP0416401A2 Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides |
03/13/1991 | EP0416396A2 Tetrasaccharides and process for their preparation |
03/13/1991 | EP0416393A1 Peptidyl difluorodiol renin inhibitors |
03/13/1991 | EP0416383A2 Substituted aminopyridines |
03/13/1991 | EP0416373A2 Amino acid derivatives |
03/13/1991 | EP0416327A2 Chemical derivatives of antibiotics LL-E19020 alpha and beta |
03/13/1991 | EP0416286A1 Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents |
03/13/1991 | EP0416248A2 Use of vitamine B6 for reducing elevated serotonin levels |
03/13/1991 | EP0416232A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
03/13/1991 | EP0416137A1 Method for reducing skin irritation associated with drug/penetration enhancer compositions |
03/13/1991 | EP0416075A1 Acryloyl substituted pyrrole derivatives |
03/13/1991 | EP0416069A1 New leucotriene b 4 derivatives, a method of preparing them, and their use as drugs. |
03/13/1991 | EP0416064A1 20-alkyl-13,14,18,18,19,19-hexadehydro-3-oxa-isocarbacycline derivatives and their pharmaceutical use |
03/13/1991 | EP0416034A1 Penetration enhancers for transdermal delivery of systemic agent |
03/13/1991 | EP0416033A1 Macrocyclic chelates and methods of use thereof. |
03/13/1991 | EP0416024A1 SUBSTITUTED 6H-PYRIDO (4,3-b) CARBAZOLES |
03/13/1991 | EP0416011A1 Chemotherapeutic composition for aids |